The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...
Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A former Florida teacher has been sentenced to 12 years in prison for sexually abusing students — with a judge denying his request to be castrated instead of serving time. Mark Lua, a former English ...
Novocure to launch Optune Lua in Japan with national reimbursement coverage Novocure (NASDAQ: NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare approved reimbursement for ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved tumor treating fields for use as part of combination treatment for certain patients with ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A Des Moines microbrewery is a finalist for the best brewpubs across the U.S., and Iowans have a chance to vote it into the top 10. Lua Brewing was nominated for USA TODAY 10Best's Readers' Choice ...
LONDON, April 16, 2026 (GLOBE NEWSWIRE)-- Lua, the operating system for human agent collaboration in the workspace, announced today it has secured $5.8M in funding led by Norrsken22. Additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results